Tymon Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 21 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 49.13%
(FY 2021)
- Profit -15.79%
(FY 2021)
- Ebitda -10.81%
(FY 2021)
- Net Worth 64.29%
(FY 2021)
- Total Assets -1.05%
(FY 2021)
About Tymon Healthcare
The Corporate was formerly known as Bliss Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Daljit Dua and Hitesh Dua serve as directors at the Company.
- CIN/LLPIN
U24232PB2003PTC026038
- Company No.
026038
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 2003
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Ludhiana, Punjab, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Tymon Healthcare Private Limited offer?
Tymon Healthcare Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Pain Balm & Ointments, Common Disease Medicines, Ear Drops, Ayurvedic & Herbal Health Supplement, Herbal Juice, Cereals & Food Grains, Flours, Nutraceuticals & Dietary Supplements, Mineral Supplement.
Who are the key members and board of directors at Tymon Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daljit Dua  | Director | 15-Dec-2004 | Current |
| Hitesh Dua | Director | 22-May-2003 | Current |
Financial Performance of Tymon Healthcare.
Tymon Healthcare Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 49.13% increase. The company also saw a substantial fall in profitability, with a 15.79% decrease in profit. The company's net worth Soared by an impressive increase of 64.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Tymon Healthcare?
In 2021, Tymon Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Tymon Healthcare?
Tymon Healthcare has a workforce of 9 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Tymon Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tymon Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
